Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Computer dosing program for the initiation of vancomycin therapy

M K Ito1, L L Duren, J S Simonian

  • 1University of the Pacific (UOP) School of Pharmacy, Stockton, CA.

Clinical Pharmacy
|February 1, 1993
PubMed
Summary

This study evaluated a computer program for vancomycin dosing, finding its initial predictions for serum concentrations had significant bias and imprecision. A revised model improved predictive performance, suggesting enhanced vancomycin therapy management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of pravastatin-to-simvastatin conversion on low-density-lipoprotein cholesterol.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2001
Same author

The relationship between low-density lipoprotein cholesterol goal attainment and prevention of coronary heart disease--related events.

Journal of cardiovascular pharmacology and therapeutics·2001
Same author

Colesevelam hydrochloride: a novel bile acid-binding resin.

The Annals of pharmacotherapy·2001
Same author

The effects of converting from simvastatin to atorvastatin on plasminogen activator inhibitor type-1.

Journal of clinical pharmacology·2001
Same author

Fenofibrate and warfarin interaction.

Pharmacotherapy·2001
Same author

Relationship between tablet splitting and compliance, drug acquisition cost, and patient acceptance.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1999

Area of Science:

  • Pharmacokinetics and Pharmacodynamics
  • Clinical Pharmacy
  • Computational Modeling

Background:

  • Vancomycin therapy requires precise dosing to achieve therapeutic serum concentrations and minimize toxicity.
  • Computer-assisted dosing programs aim to optimize vancomycin initiation.
  • Accurate prediction of pharmacokinetic parameters like volume of distribution (V) and clearance (CL) is crucial for effective dosing.

Purpose of the Study:

  • To assess the predictive performance of a computer dosing program (T.D.M.S.) for initiating vancomycin therapy.
  • To compare population-based pharmacokinetic estimates with patient-specific data derived from Bayesian analysis (BA) and non-linear least-squares regression (NLLS).
  • To evaluate the impact of a revised clearance model on the predictive accuracy of vancomycin dosing.

Main Methods:

Related Experiment Videos

  • Prospective study involving 31 adult patients receiving vancomycin.
  • Estimation of initial serum vancomycin concentrations using a two-compartment open model computer program.
  • Collection of 62 steady-state serum vancomycin concentrations (Css) for comparison with estimated values.
  • Evaluation of bias and precision using median error (ME) and median absolute error (MAE).
  • Comparison of population V and CL estimates with BA and NLLS-derived values.

Main Results:

  • The computer program exhibited significant bias and imprecision in predicting peak and trough Css.
  • Patient-specific CL values derived from BA and NLLS were significantly higher than the population-based estimate.
  • Median V values determined by BA and NLLS did not differ significantly from the population-based estimate.
  • A revised clearance model, developed using BA, improved the predictive performance of the a priori model in a validation cohort.

Conclusions:

  • The initial computer dosing program for vancomycin therapy demonstrated suboptimal predictive performance.
  • Individualized pharmacokinetic parameter estimation, particularly for clearance, is essential for accurate vancomycin dosing.
  • A revised clearance model shows promise for enhancing the accuracy of computer-assisted vancomycin dosing strategies.